Source: Clinica Chimica Acta. Unidade: FMRP
Subjects: LEUCEMIA, POLIMORFISMO, ENDOTÉLIO VASCULAR, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clinica Chimica Acta, v. 411, n. 17-18, p. 1335-1340, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2010.05.025. Acesso em: 05 nov. 2024.APA
Demacq, C., Vasconcellos, V. B., Izidoro-Toledo, T. C., Silveira, V. da S., Canalle, R., Queiroz, R. G. de P., et al. (2010). Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clinica Chimica Acta, 411( 17-18), 1335-1340. doi:10.1016/j.cca.2010.05.025NLM
Demacq C, Vasconcellos VB, Izidoro-Toledo TC, Silveira V da S, Canalle R, Queiroz RG de P, Tone LG, Tanus-Santos JE. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) [Internet]. Clinica Chimica Acta. 2010 ; 411( 17-18): 1335-1340.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.cca.2010.05.025Vancouver
Demacq C, Vasconcellos VB, Izidoro-Toledo TC, Silveira V da S, Canalle R, Queiroz RG de P, Tone LG, Tanus-Santos JE. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) [Internet]. Clinica Chimica Acta. 2010 ; 411( 17-18): 1335-1340.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.cca.2010.05.025
